dict.md logo
Results for P in English, page 85
Patient position finding
Patient Positioning
Patient Positionings
patient pre-assessment
Patient Preference
Patient Preferences
patient privacy
Patient Problem
Patient Problem Code
Patient Problem Codes FDA CDRH
Patient problem message
Patient problem outcome
Patient problem outcome | patient
Patient problem outcome | patient | Bld-Ser-Plas
Patient problem outcome:Find:Pt:^Patient:Nar
Patient problem outcome:Finding:Point in time:^Patient:Narrative
Patient problem response
Patient Problem Terminology FDA CDRH
Patient Problem Terminology FDA Center for Devices and Radiological Health
patient processing
PATIENT PROF DIS TRANSM
PATIENT PROF TRANSM
patient professional relations
Patient progr, neurostim
PATIENT PROGRAMMER (EXTERNAL) FOR USE WITH IMPLANTABLE PROGRAMMABLE NEUROSTIMULATOR PULSE GENERATOR, REPLACEMENT ONLY
PATIENT PROGRAMMER, NEUROSTIMULATOR
PATIENT PRONOUNCED DEAD AFTER AMBULANCE CALLED
patient psychological history
patient psychological status
patient psychotherapist interaction
Patient queried and counseled about anti-epileptic drug (AED) side effects (EPI)
Patient Readmission
Patient Readmissions
Patient receiving <10 mg daily prednisone (or equivalent), or RA activity is worsening, or glucocorticoid use is for less than 6 months (RA)
Patient receiving >=10 mg daily prednisone (or equivalent) for longer than 6 months, and improvement or no change in disease activity (RA)
PATIENT RECEIVING ANGIOTENSIN CONVERTING ENZYME (ACE) INHIBITOR OR ANGIOTENSIN RECEPTOR BLOCKER (ARB) THERAPY
PATIENT RECEIVING ANTIVIRAL TREATMENT FOR HEPATITIS C
PATIENT RECEIVING ANTIVIRAL TREATMENT FOR HEPATITIS C DOCUMENTED
Patient receiving or eligible to receive foods, fluids or medication by mouth
Patient receiving potent antiretroviral therapy for 6 months or longer (HIV)
Patient receiving potent antiretroviral therapy for less than 6 months or not receiving potent antiretroviral therapy (HIV)
Patient receiving warfarin therapy for nonvalvular atrial fibrillation or atrial flutter (AFIB)
Patient Record, Computerized
patient records
Patient Records, Computerized
Patient recovered
Patient recovered | patient
Patient recovered | patient | Bld-Ser-Plas
Patient recovered:ACnc:Pt:^Patient:Ord
Patient recovered:Arbitrary Concentration:Point in time:^Patient:Ordinal
Patient Recruitment
Patient Recruitments
Patient referral
PATIENT REFERRED TO A PHYSICIAN (PREFERABLY A PHYSICIAN WITH TRAINING IN DISORDERS OF THE EAR) FOR AN OTOLOGIC EVALUATION
Patient Refusal of Treatment
Patient registered - FP4
Patient registered GP4 (COMP)S
Patient registration-"ghosts"
patient registry
Patient Relations, Nurse
Patient Relationship, Nurse
Patient Relationships, Nurse
patient reported having 'bad blood' (history)
patient reported having 'low blood' (history)
patient reported having 'sugar' (history)
Patient Repositioning
Patient Repositionings
Patient Representative
Patient Representatives
Patient Request
Patient requested information not be shared with next provider
Patient requested information not be shared with next provider | patient
Patient requested information not be shared with next provider | patient | Bld-Ser-Plas
Patient requested information not be shared with next provider CARE
Patient requested information not be shared with next provider:Find:Pt:^Patient:Ord:CARE
Patient requested information not be shared with next provider:Finding:Point in time:^Patient:Ordinal:CARE
Patient requiring intermittent renal dialysis
Patient responsible for self
Patient responsible for self | patient
Patient responsible for self | patient | Bld-Ser-Plas
patient retention
Patient Right
Patient Rights
patient risk management
Patient Rollers
Patient Room
Patient Rooms
patient safety
Patient Safety Codes for Performance Measurement
Patient Safety LOINC Clinical Class
Patient safety order set
Patient Safety Panel
Patient safety report
Patient safety report | Event
Patient safety report | Event | Bld-Ser-Plas
Patient safety report Event Doc
Patient safety report Event Document
Patient safety report:Find:Pt:^Event:Doc
Patient safety report:Finding:Point in time:^Event:Document
Patient Safety Topics
patient safety/medical error
Patient Satisfaction
Patient Scales
Patient Schedule
Patient Schedules
PATIENT SCREENED FOR FUTURE FALL RISK; DOCUMENTATION OF NO FALLS IN THE PAST YEAR OR ONLY ONE FALL WITHOUT INJURY IN THE PAST YEAR
PATIENT SCREENED FOR FUTURE FALLS RISK; DOCUMENTATION OF TWO OR MORE FALLS IN THE PAST YEAR OR ANY FALL WITH INJURY IN THE PAST YEAR
Patient screened for high-risk sexual behavior (HIV)
Patient Seclusion
Patient Security Systems
Patient Selection
Patient Selections
Patient Self Determination Act
Patient Self-Determination Act
Patient Self-Report
Patient Service Consoles
Patient Service Headwall Systems
Patient Signature on Informed Consent Form
Patient Simulation
Patient Simulations
Patient Simulators
patient social functioning
patient social history
Patient Specimen Culture
Patient State
Patient Status Code
patient supervision
patient support services
patient survey
patient surveys
Patient symptoms
Patient symptoms [interpretation] --1 hour post dose lactose PO
Patient symptoms [interpretation] --1.5 hours post dose lactose PO
Patient symptoms [interpretation] --2 hours post dose lactose PO
Patient symptoms [interpretation] --2.5 hours post dose lactose PO
Patient symptoms [interpretation] --3 hours post dose lactose PO
Patient symptoms [interpretation] --30 minutes post dose lactose PO
Patient symptoms [interpretation] --pre dose lactose PO
Patient symptoms | Patient
Patient symptoms | Patient | Bld-Ser-Plas
Patient symptoms^1 1/2 hours post dose lactose Oral:Impression/interpretation of study:Point in time:^Patient:Narrative
Patient symptoms^1 1/2 hours post dose lactose Oral:Impression/interpretation of study:Point in time:^Patient:Nominal
Patient symptoms^1 hour post dose lactose Oral:Impression/interpretation of study:Point in time:^Patient:Narrative
Patient symptoms^1 hour post dose lactose Oral:Impression/interpretation of study:Point in time:^Patient:Nominal
Patient symptoms^1.5H post dose lactose PO:Imp:Pt:^Patient:Nar
Patient symptoms^1.5H post dose lactose PO:Imp:Pt:^Patient:Nom
Patient symptoms^1H post dose lactose PO:Imp:Pt:^Patient:Nar
Patient symptoms^1H post dose lactose PO:Imp:Pt:^Patient:Nom
Patient symptoms^2 1/2 hours post dose lactose Oral:Impression/interpretation of study:Point in time:^Patient:Narrative
Patient symptoms^2 1/2 hours post dose lactose Oral:Impression/interpretation of study:Point in time:^Patient:Nominal
Patient symptoms^2 hours post dose lactose Oral:Impression/interpretation of study:Point in time:^Patient:Narrative
Patient symptoms^2 hours post dose lactose Oral:Impression/interpretation of study:Point in time:^Patient:Nominal
Patient symptoms^2.5H post dose lactose PO:Imp:Pt:^Patient:Nar
Patient symptoms^2.5H post dose lactose PO:Imp:Pt:^Patient:Nom
Patient symptoms^2H post dose lactose PO:Imp:Pt:^Patient:Nar
Patient symptoms^2H post dose lactose PO:Imp:Pt:^Patient:Nom
Patient symptoms^3 hours post dose lactose Oral:Impression/interpretation of study:Point in time:^Patient:Narrative
Patient symptoms^3 hours post dose lactose Oral:Impression/interpretation of study:Point in time:^Patient:Nominal
Patient symptoms^30 minutes post dose lactose Oral:Impression/interpretation of study:Point in time:^Patient:Narrative
Patient symptoms^30 minutes post dose lactose Oral:Impression/interpretation of study:Point in time:^Patient:Nominal
Patient symptoms^30M post dose lactose PO:Imp:Pt:^Patient:Nar
Patient symptoms^30M post dose lactose PO:Imp:Pt:^Patient:Nom
Patient symptoms^3H post dose lactose PO:Imp:Pt:^Patient:Nar
Patient symptoms^3H post dose lactose PO:Imp:Pt:^Patient:Nom
Patient symptoms^post transfusion reaction:Imp:Pt:^Patient:Nar
Patient symptoms^post transfusion reaction:Impression/interpretation of study:Point in time:^Patient:Narrative
Patient symptoms^pre dose lactose Oral:Impression/interpretation of study:Point in time:^Patient:Narrative
Patient symptoms^pre dose lactose Oral:Impression/interpretation of study:Point in time:^Patient:Nominal
Patient symptoms^pre dose lactose PO:Imp:Pt:^Patient:Nar
Patient symptoms^pre dose lactose PO:Imp:Pt:^Patient:Nom
Patient symptoms--1 hour post dose lactose PO
Patient symptoms--1.5 hours post dose lactose PO
Patient symptoms--2 hours post dose lactose PO
Patient symptoms--2.5 hours post dose lactose PO
Patient symptoms--3 hours post dose lactose PO
Patient symptoms--30 minutes post dose lactose PO
Patient symptoms--after transfusion reaction
Patient symptoms--pre dose lactose PO
Patient Table Relationship
Patient Thermometers
Patient to Professional Disease Transmission
Patient to Professional Transmission
Patient Tracking System
Patient Transfer
Patient Transfer Aids
Patient Transfer Aids, Lateral Transfer
Patient Transfer Boards
Patient Transfer Chairs
Patient Transfer Mattresses
Patient Transfer Slings
Patient Transfer Stretchers
Patient transfer system <300
Patient transfer system >300
Patient Transfers
Patient Transport
patient transport ambulance /PTA/
Patient Transport Monitors
Patient transportation request
Patient transportation request | patient
Patient transportation request | patient | Bld-Ser-Plas
Patient transportation request Doc
Patient transportation request Document
Patient transportation request:Find:Pt:^Patient:Doc
Patient transportation request:Finding:Point in time:^Patient:Document
patient treatment factors
patient treatment history
Patient Treatment Permit, Release & Admission
Patient Treatment Permit, Release & Admission - Consent Type
Patient Type
Patient undergoing in vitro fertilization cycle
Patient unstable as reason of limitation
Patient Utensil Kits
patient views of treatment
Patient Visitors
Patient w/mild syst disease
Patient w/severe sys disease
Patient walks to diagnostic service
Patient Wandering Prevention Systems
PATIENT WAS NOT AN ELIGIBLE CANDIDATE FOR CEFAZOLIN OR CEFUROXIME FOR ANTIMICROBIAL PROPHYLAXIS
PATIENT WAS NOT AN ELIGIBLE CANDIDATE FOR COMMUNICATION WITH THE PHYSICIAN MANAGING THE PATIENT'S ONGOING CARE THAT A FRACTURE OCCURRED AND THAT THE PATIENT WAS OR SHOULD BE TESTED OR TREATED FOR OSTEOPOROSIS
PATIENT WAS NOT AN ELIGIBLE CANDIDATE FOR COMPLETE PHYSICAL SKIN EXAM DURING THE REPORTING YEAR
PATIENT WAS NOT AN ELIGIBLE CANDIDATE FOR COUNSELING TO PERFORM SELF-EXAMINATION
PATIENT WAS NOT AN ELIGIBLE CANDIDATE FOR DISCHARGE MEDICATIONS REVIEW
PATIENT WAS NOT AN ELIGIBLE CANDIDATE FOR DOCUMENTATION OF PRESENCE OR ABSENCE OF ALARM SYMPTOMS
PATIENT WAS NOT AN ELIGIBLE CANDIDATE FOR DVT PROPHYLAXIS BY END OF HOSPITAL DAY 2, INCLUDING PHYSICIAN DOCUMENTATION THAT PATIENT IS AMBULATORY
PATIENT WAS NOT AN ELIGIBLE CANDIDATE FOR MEDICAL HISTORY REVIEW WITH ASSESSMENT OF NEW OR CHANGING MOLES
PATIENT WAS NOT AN ELIGIBLE CANDIDATE FOR PRE-SURGICAL FUNDUS EVALUATION
PATIENT WAS NOT REFERRED TO A PHYSICIAN (PREFERABLY A PHYSICIAN WITH TRAINING IN DISORDERS OF THE EAR) FOR AN OTOLOGIC EVALUATION, REASON NOT SPECIFIED)
PATIENT WAS NOT SCORED ON THE ATTENTION FUNCTIONAL COMMUNICATION MEASURE EITHER AT ADMISSION OR AT DISCHARGE
PATIENT WAS NOT SCORED ON THE MEMORY FUNCTIONAL COMMUNICATION MEASURE AT EITHER ADMISSION OR AT DISCHARGE
PATIENT WAS NOT SCORED ON THE MOTOR SPEECH FUNCTIONAL COMMUNICATION MEASURE EITHER AT ADMISSION OR AT DISCHARGE
PATIENT WAS NOT SCORED ON THE READING FUNCTIONAL COMMUNICATION MEASURE EITHER AT ADMISSION OR AT DISCHARGE
PATIENT WAS NOT SCORED ON THE SPOKEN LANGUAGE COMPREHENSION FUNCTIONAL COMMUNICATION MEASURE EITHER AT ADMISSION OR AT DISCHARGE
PATIENT WAS NOT SCORED ON THE SPOKEN LANGUAGE EXPRESSION FUNCTIONAL COMMUNICATION MEASURE EITHER AT ADMISSION OR AT DISCHARGE
PATIENT WAS NOT SCORED ON THE SWALLOWING FUNCTIONAL COMMUNICATION MEASURE AT ADMISSION OR AT DISCHARGE
PATIENT WAS NOT SCORED ON THE WRITING FUNCTIONAL COMMUNICATION MEASURE EITHER AT ADMISSION OR AT DISCHARGE
patient was observed to choke (history)
PATIENT WAS REFERRED TO A PHYSICIAN (PREFERABLY A PHYSICIAN WITH TRAINING IN DISORDERS OF THE EAR) FOR AN OTOLOGIC EVALUATION, REASON NOT SPECIFIED)
Patient will live with at discharge
Patient will live with at discharge | patient
Patient will live with at discharge | patient | Bld-Ser-Plas
Patient will live with at discharge CARE
Patient will live with at discharge:Find:Pt:^Patient:Nom:CARE
Patient will live with at discharge:Finding:Point in time:^Patient:Nominal:CARE
PATIENT WITH ALARM SYMPTOM(S) DOCUMENTED TO HAVE HAD UPPER ENDOSCOPY PERFORMED OR REFERRAL FOR UPPER ENDOSCOPY
PATIENT WITH AT LEAST ONE ALARM SYMPTOM NOT DOCUMENTED TO HAVE HAD UPPER ENDOSCOPY OR REFERRAL FOR UPPER ENDOSCOPY
PATIENT WITH CENTRAL DUAL-ENERGY X-RAY ABSORPTIOMETRY (DXA) RESULTS DOCUMENTED OR ORDERED OR PHARMACOLOGIC THERAPY (OTHER THAN MINERALS/VITAMINS) FOR OSTEOPOROSIS PRESCRIBED)
PATIENT WITH CENTRAL DUAL-ENERGY X-RAY ABSORPTIOMETRY (DXA) RESULTS NOT DOCUMENTED OR NOT ORDERED OR PHARMACOLOGIC THERAPY (OTHER THAN MINERALS/VITAMINS) FOR OSTEOPOROSIS NOT PRESCRIBED
PATIENT WITH DOCUMENTED RECEIPT OF THROMBOEMBOLISM PROPHYLAXIS
Patient with factor IX Leyden variants (see, e.g., {300746.0001}) have bleeding in childhood that improves or resolves after puberty
PATIENT WITH HEART FAILURE AND ATRIAL FIBRILLATION DOCUMENTED TO BE ON WARFARIN THERAPY
PATIENT WITH ISOLATED CORONARY ARTERY BYPASS GRAFT DID NOT REQUIRE SURGICAL RE-EXPLORATION
PATIENT WITH ISOLATED CORONARY ARTERY BYPASS GRAFT DOCUMENTED TO HAVE BEEN DISCHARGED ON ASPIRIN OR CLOPIDOGREL
PATIENT WITH ISOLATED CORONARY ARTERY BYPASS GRAFT DOCUMENTED TO HAVE PROLONGED INTUBATION
PATIENT WITH ISOLATED CORONARY ARTERY BYPASS GRAFT DOCUMENTED TO HAVE RECEIVED PRE-OPERATIVE BETA-BLOCKADE
PATIENT WITH ISOLATED CORONARY ARTERY BYPASS GRAFT DOCUMENTED TO HAVE REQUIRED SURGICAL RE-EXPLORATION
PATIENT WITH ISOLATED CORONARY ARTERY BYPASS GRAFT NOT DOCUMENTED TO HAVE BEEN DISCHARGED ON ASPIRIN OR CLOPIDOGREL
PATIENT WITH ISOLATED CORONARY ARTERY BYPASS GRAFT NOT DOCUMENTED TO HAVE PROLONGED INTUBATION
PATIENT WITH ISOLATED CORONARY ARTERY BYPASS GRAFT NOT DOCUMENTED TO HAVE RECEIVED PRE-OPERATIVE BETA-BLOCKADE
PATIENT WITH LEFT VENTRICULAR EJECTION FRACTION (LVEF) >=40% OR DOCUMENTATION AS NORMAL OR MILDLY DEPRESSED LEFT VENTRICULAR SYSTOLIC FUNCTION
PATIENT WITH NO DOCUMENTATION OF CALCIUM AND VITAMIN D USE OR COUNSELING REGARDING BOTH CALCIUM AND VITAMIN D USE, OR EXERCISE
PATIENT WITH NO DOCUMENTATION OF SCREENING FOR FALL RISKS (2 OR MORE FALLS IN THE PAST YEAR OR ANY FALL WITH INJURY IN THE PAST YEAR)
PATIENT WITH NO DOCUMENTATION ORDER FOR BARIUM SWALLOW TEST
PATIENT WITH SUSPICION OF BARRETT'S ESOPHAGUS IN ENDOSCOPY REPORT AND DOCUMENTED TO HAVE RECEIVED AN ESOPHAGEAL BIOPSY
Patient with truncating mutations are more likely to develop neurologic abnormalities
PATIENT WITHOUT DOCUMENTED RECEIPT OF THROMBOEMBOLISM PROPHYLAXIS
patient work-up
Patient_s Relationship to Insured
Patient_s Relationship to Insured - Cadaver donor
Patient_s Relationship to Insured - Foster child
Patient_s Relationship to Insured - Grandchild
Patient_s Relationship to Insured - grandparent
Patient_s Relationship to Insured - Organ donor
Patient_s Relationship to Insured - Parent
Patient_s Relationship to Insured - Spouse
Patient_s Relationship to Insured - Step child
Patient-Centered Care
Patient-Centered Nursing
Patient-Centered Outcomes
Patient-confidential section
Patient-confidential section | patient
Patient-confidential section | patient | Bld-Ser-Plas
Patient-confidential section Set NAACCR
Patient-confidential section:-:Point in time:^Patient:Set:NAACCR
Patient-confidential section:-:Pt:^Patient:Set:NAACCR
Patient-Controlled Analgesia
Patient-Controlled Analgesia Units
Patient-device incompatibility
Patient-Device Incompatibility Medical Device Problem
Patient-Device Interaction
Patient-Device Interactions
Patient-Family Lodging
Patient-Family Lodgings
Patient-Focused Care
Patient-Focused Outcomes
patient-friendly
Patient-initiated spirometric recording per 30-day period of time; includes reinforced education, transmission of spirometric tracing, data capture, analysis of transmitted data, periodic recalibration and physician review and interpretation
Patient-initiated spirometric recording per 30-day period of time; recording (includes hook-up, reinforced education, data transmission, data capture, trend analysis, and periodic recalibration)
patient-matching variables
Patient-Professional Disease Transmission
Patient-Professional Infection Transmission
Patient-Professional Infection Transmissions
Patient-Professional Pathogen Transmission
Patient-Professional Transmission
patient-provider relationship
patient-reported outcome (PRO)
Patient-specific parameters for notifying physician of changes
Patient-specific parameters for notifying physician of changes | patient
Patient-specific parameters for notifying physician of changes | patient | Bld-Ser-Plas
Patient-to-Professional Disease Transmission
Patient-to-Professional Transmission
patient-treatment matching
Patient-Worn Monitors
Patient, Immunocompromised
Patient, no consequences or impact to
Patient's Age and Age at Onset of the Main Problem
Patient's Medicare number
Patient's Residence
Patient's Residence - RoleCode
Patient's Right
Patient's Rights
patient's room
Patient's Rooms
Patient's Sex
Patient's Signature on Informed Consent Form
Patient's Visitors
Patient/caregiver drug education intervention | patient
Patient/caregiver drug education intervention | patient | Bld-Ser-Plas
Patient/caregiver high risk drug education | patient
Patient/caregiver high risk drug education | patient | Bld-Ser-Plas
patient/disease registry
Patient/Family Housing
Patient/Person Name is an Alias
Patient/Public Education About Cancer
Patient/Staff Communication Aids
PatientCharacteristicObservationType
PatientImportance
PatientImportance - CodeSystem
patiently
patientoside A
patientoside B
Patients
Patients 20-30 years old have hyperintense lesions on T2-weighted MRI in the frontal and anterior temporal lobes
Patients 30-40 years old have hyperintense lesions in periventricular areas, the external capsule, basal ganglia, thalamus, and brainstem
Patients achieve ambulation
Patients achieve independent ambulation
Patients are often asymptomatic
Patients are often of Mediterranean origin
patients belonging to medical insurance scheme
Patients between 30 and 60 years have discomfort with prolonged standing
Patients can be divided into 2 groups based on whether typical hand anomalies are present
PATIENTS DIAGNOSED WITH SYMPTOMATIC OSTEOARTHRITIS WITH DOCUMENTED ANNUAL ASSESSMENT OF FUNCTION AND PAIN
Patients do not have clinical hypothyroidism
Patients have supernumerary chromosome - 47,XX(or XY), +der(22), +(11:22)(q23:q11)
Patients look as if they have protein deficiency or malnutrition
Patients may become bedridden 10 to 20 years after onset
Patients may become ventilator-dependent
Patients may become wheelchair-bound after about 12 years
Patients may develop a seizure disorder later in life
Patients may have a combination phenotype of PMC and HYPP (see {603967.0005})
Patients may have distal or proximal muscle weakness, or both
Patients may have head and neck paragangliomas only, adrenal or extraadrenal pheochromocytomas only, or both
Patients may have no structural abnormalities in the central nervous system
Patients may have seizures only, dyskinesia only, or both
Patients may or may not have dysmorphic features
Patients may show normal development
Patients need lifelong total parenteral nutrition
Patients of Brazilian origin have a pure cerebellar atrophy
Patients of Mexican or Amerindian origin have a complicated phenotype with additional neurologic features
Patients often become wheelchair-bound
Patients often become wheelchair-bound 3 to 4 decades after onset
Patients often have a more severe and complicated phenotype in addition to PEO
Patients often nonambulatory by mid-20s
Patients older than 50 years have hyperintensities, lacunar infarcts, and microbleeds
Patients older than 60 years have severe degenerative arthritis in the feet
Patients present with skin lesions followed by gingival fibromatosis
Patients remain ambulatory
Patients retain ambulation even after long disease course
Patients Rights
Patients Rooms
Patients show normal psychomotor development
Patients show sorbitol and glycerol intolerance
Patients Transportation
Patients Transportations
Patients usually require total thyroidectomy
Patients Visitors
Patients walk on tips of toes with dorsal foot deviated laterally
Patients with a more severe phenotype have been reported with mutations in more than 1 LQTS-related gene
Patients with adult onset present with psychiatric features
Patients with atypical form have milder disease, with onset in the first months of life and increased survival
Patients with autosomal dominant inheritance and a single GDAP1 mutation have a less severe course with later onset
Patients with glaucoma have nonsense or truncating SBF2 mutations ({607697.0002})
Patients with hemophilia B(M) variants (see, e.g., {300746.0030}) also have prolonged PT
Patients with homozygous mutations have a more severe disorder
Patients with hypothyroidism have hypoplastic thyroid gland
Patients with later onset do not have dysmorphic features
Patients with later onset have better prognosis
Patients with more severe phenotype have been reported with mutations in more than 1 LQT-related gene
Patients with more severe phenotype have been reported with mutations in more than 1 LQTS-related gene
Patients with mutations in the CHRNE gene have a milder phenotype because fetal CHRNG ({100730}) exhibits phenotypic rescue
Patients with mutations in the NHLRC1 gene have slightly longer survival
Patients with null mutations have neonatal onset within 72 hours of birth
Patients with null mutations in (CTSD) show a more severe phenotype with onset at birth ('congenital NCL') and early death within days
PATIENTS WITH PERSISTENT ASTHMA, NO DOCUMENTATION OF PREFERRED LONG TERM CONTROL MEDICATION OR ACCEPTABLE ALTERNATIVE TREATMENT PRESCRIBED
Patients with residual enzyme activity have childhood or adult onset
Patients with somatic mutations may show hyperproliferation of other myeloid lineages
Patients with T2 deficiency and urinary abnormalities may be asymptomatic
Patients with total C4 deficiency are homozygous for double null C4 haplotype
Patients with variant CJD are homozygous for met129 polymorphism ({176640.0005})
Patients younger than 30 years complain only that they cannot run fast
Patients, Immunocompromised
patients' association
patients' associations
patients' charter
Patients' Right
Patients' Rights
Patients' Room
Patients' Rooms
Patients' Visitor
Patients' Visitors
Patina
Patina pellucida
Patinella
Patinella tenebricosa
patinized
Patinoa
Patinoa sphaerocarpa
Patinopecten
Patinopecten caurinus
Patinopecten sp.
Patinopecten yessoensis
Patinopectens
patinosterol
patio
patio heater
Patiopecten yessoensis
patios
Patiria
Patiria chilensis
Patiria miniata
Patiria pectinifera
Patiriella
Patiriella aucklandensis
Patiriella calcar
Patiriella calcarata
Patiriella exigua
Patiriella exigua (Lamarck, 1816)
Patiriella gunnii
Patiriella medius
Patiriella mortenseni
Patiriella occidens
Patiriella oriens
Patiriella parvivipara
Patiriella pseudoexigua
Patiriella regularis
Patiriella vivipara
patisserie
PATJ
PATJ protein, Drosophila
PATJ protein, human
patkuko
PATL1 gene
PATL1 protein, Arabidopsis
PATL1 protein, human
PATL2 gene
Patlak Analysis
Patlak Plot
patly
patman
PATMC
PATMK protein, Entamoeba histolytica
PATMPC
Patna (city in India)
patois
patologic
patology
Patoran
Patosia
Patosia Buchenau
Patosia clandestina
Patosia clandestina (Phil.) Buchenau
PATP
patriach
patriaches
patriarcal
patriarch
patriarchal
patriarchal cross
patriarchal family
patriarchate
patriarchic
Patriarchies
Patriarchy
patriate
patriated
patriates
patriatest
patriateth
patriating
Patricia
83 84 85 86 87